Literature DB >> 23070761

Combined fluorimetric caspase 3/7 assay and bradford protein determination for assessment of polycation-mediated cytotoxicity.

Anna K Larsen1, Arnaldur Hall, Henrik Lundsgart, S Moein Moghimi.   

Abstract

Cationic polyplexes and lipoplexes are widely used as artificial systems for nucleic acid delivery into the cells, but they can also induce cell death. Mechanistic understanding of cell toxicity and biological side effects of these cationic entities is essential for optimization strategies and design of safe and efficient nucleic acid delivery systems. Numerous methods are presently available to detect and delineate cytotoxicity and cell death-mediated signals in cell cultures. Activation of caspases is part of the classical apoptosis program and increased caspase activity is therefore a well-established hallmark of programmed cell death. Additional methods to monitor cell death-related signals must, however, also be carried out to fully define the type of cell toxicity in play. These may include methods that detect plasma membrane damage, loss of mitochondrial membrane potential, phosphatidylserine exposure, and cell morphological changes (e.g., membrane blebbing, nuclear changes, cytoplasmic swelling, cell rounding). Here we describe a 96-well format protocol for detection of capsase-3/7 activity in cell lysates, based on a fluorescent caspase-3 assay, combined with a method to simultaneously determine relative protein contents in the individual wells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23070761     DOI: 10.1007/978-1-62703-140-0_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Carbohydrate Modifications of Neoandrographolide for Improved Reactive Oxygen Species-Mediated Apoptosis through Mitochondrial Pathway in Colon Cancer.

Authors:  Venu Sharma; Arem Qayum; Sanjana Kaul; Ajeet Singh; Kamal K Kapoor; Debaraj Mukherjee; Shashank K Singh; Manoj K Dhar
Journal:  ACS Omega       Date:  2019-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.